CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical College of Wisconsin
Akeso
Eastern Cooperative Oncology Group
Arcus Biosciences, Inc.
Lokon Pharma AB
SWOG Cancer Research Network
FutureGen Biopharmaceutical (Beijing) Co., Ltd
NRG Oncology
Emory University
Queen Mary University of London
Alliance for Clinical Trials in Oncology
Mayo Clinic
Suzhou Transcenta Therapeutics Co., Ltd.
Emory University
University Health Network, Toronto
M.D. Anderson Cancer Center
Jinling Hospital, China
University of Southern California
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Verastem, Inc.
University of Iowa
Emory University
University of Colorado, Denver
AHS Cancer Control Alberta
Columbia University
SynerGene Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Beth Israel Deaconess Medical Center
EBG MedAustron GmbH
Precision Biologics, Inc
InxMed (Shanghai) Co., Ltd.
NovoCure Ltd.
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
iOnctura
Herlev Hospital
Aalborg University Hospital
Shanghai Zhongshan Hospital
Takara Bio Inc.
Actuate Therapeutics Inc.
Panbela Therapeutics, Inc.
Lisata Therapeutics, Inc.
University of Oxford
OHSU Knight Cancer Institute
Shanghai Zhongshan Hospital
Salspera LLC
OHSU Knight Cancer Institute